Analysts forecast that Stericycle Inc (NASDAQ:SRCL) will post earnings per share (EPS) of $0.83 for the current quarter, Zacks reports. Eight analysts have made estimates for Stericycle’s earnings. The lowest EPS estimate is $0.80 and the highest is $0.88. Stericycle posted earnings per share of $1.17 during the same quarter last year, which would indicate a negative year over year growth rate of 29.1%. The company is scheduled to announce its next quarterly earnings report on Thursday, August 1st.
On average, analysts expect that Stericycle will report full-year earnings of $3.31 per share for the current financial year, with EPS estimates ranging from $3.12 to $3.53. For the next financial year, analysts forecast that the business will report earnings of $3.86 per share, with EPS estimates ranging from $3.59 to $4.81. Zacks Investment Research’s earnings per share calculations are an average based on a survey of research firms that follow Stericycle.
Stericycle (NASDAQ:SRCL) last released its quarterly earnings data on Thursday, May 2nd. The business services provider reported $0.57 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.87 by ($0.30). Stericycle had a negative net margin of 8.92% and a positive return on equity of 12.56%. The business had revenue of $830.10 million during the quarter, compared to analyst estimates of $866.19 million. During the same period in the previous year, the business earned $1.21 earnings per share. The business’s quarterly revenue was down 7.3% on a year-over-year basis.
Shares of SRCL traded down $0.09 during mid-day trading on Wednesday, reaching $44.89. The company’s stock had a trading volume of 522,567 shares, compared to its average volume of 1,105,447. Stericycle has a 1-year low of $34.36 and a 1-year high of $71.43. The stock has a market cap of $4.03 billion, a price-to-earnings ratio of 10.09, a PEG ratio of 1.77 and a beta of 1.24. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 1.17.
In related news, Director Mark C. Miller sold 260,314 shares of Stericycle stock in a transaction that occurred on Tuesday, April 9th. The stock was sold at an average price of $57.18, for a total transaction of $14,884,754.52. Following the completion of the sale, the director now directly owns 325,848 shares of the company’s stock, valued at approximately $18,631,988.64. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 2.30% of the company’s stock.
A number of large investors have recently added to or reduced their stakes in the stock. Louisiana State Employees Retirement System raised its holdings in Stericycle by 0.9% in the 1st quarter. Louisiana State Employees Retirement System now owns 22,800 shares of the business services provider’s stock valued at $1,241,000 after acquiring an additional 200 shares in the last quarter. Fifth Third Bancorp raised its holdings in Stericycle by 1.8% in the 1st quarter. Fifth Third Bancorp now owns 15,149 shares of the business services provider’s stock valued at $824,000 after acquiring an additional 272 shares in the last quarter. EagleClaw Capital Managment LLC raised its holdings in Stericycle by 2.3% in the 1st quarter. EagleClaw Capital Managment LLC now owns 13,150 shares of the business services provider’s stock valued at $716,000 after acquiring an additional 300 shares in the last quarter. Cambridge Investment Research Advisors Inc. raised its holdings in Stericycle by 5.8% in the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 6,650 shares of the business services provider’s stock valued at $244,000 after acquiring an additional 366 shares in the last quarter. Finally, Bbva Compass Bancshares Inc. raised its holdings in Stericycle by 4.7% in the 1st quarter. Bbva Compass Bancshares Inc. now owns 9,716 shares of the business services provider’s stock valued at $529,000 after acquiring an additional 439 shares in the last quarter. 96.52% of the stock is owned by institutional investors and hedge funds.
Stericycle Company Profile
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It operates through three segments: Domestic and Canada Regulated Waste and Compliance; International Regulated Waste and Compliance; and Domestic Communication and Related Services.
Recommended Story: How is the LIBOR rate calculated?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.